Catalyst Wire Dossier Catalyst Wire Dossier

Bupropion hydrochloride sustained-release

Bupropion hydrochloride · ScieGen Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Bupropion hydrochloride sustained-release, covering 2009-03-24 to 2024-05-07. Get the full timeline:

Most recent: FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Supplemental Application (ScieGen Pharmaceuticals, Inc.)

See pricing